{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T03:57:22Z","timestamp":1794974242194,"version":"4.9.1"},"reference-count":50,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2015,9,16]],"date-time":"2015-09-16T00:00:00Z","timestamp":1442361600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brit J Clinical Pharma"],"published-print":{"date-parts":[[2016,3]]},"abstract":"<jats:p>Antivenom is the mainstay of treatment of snakebite envenoming. However, adverse reactions to snake antivenom that is available are common in many parts of the world where snakebite is prevalent. Both acute (anaphylactic or pyrogenic) and delayed (serum sickness type) reactions occur. Acute reactions are usually mild but severe systemic anaphylaxis may develop, often within an hour or so of exposure to antivenom. Serum sickness after antivenom has a delayed onset between 5 and 14 days after its administration. Ultimately, the prevention reactions will depend mainly on improving the quality of antivenom. Until these overdue improvements take place, doctors will have to depend on pharmacological prophylaxis, where the search for the best prophylactic agent is still on\u2010going, as well as careful observation of patients receiving antivenom in preparation for prompt management of acute as well as delayed reactions when they occur.<\/jats:p>","DOI":"10.1111\/bcp.12739","type":"journal-article","created":{"date-parts":[[2015,8,10]],"date-time":"2015-08-10T06:32:55Z","timestamp":1439188375000},"page":"446-452","source":"Crossref","is-referenced-by-count":240,"title":["Adverse reactions to snake antivenom, and their prevention and treatment"],"prefix":"10.1111","volume":"81","author":[{"given":"H. Asita","family":"de Silva","sequence":"first","affiliation":[{"name":"Clinical Trials Unit, Faculty of Medicine University of Kelaniya  Ragama Sri Lanka"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole M.","family":"Ryan","sequence":"additional","affiliation":[{"name":"Clinical Toxicology Research Group, School of Medicine and Public Health The University of Newcastle  Newcastle NSW Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Janaka","family":"de Silva","sequence":"additional","affiliation":[{"name":"Clinical Trials Unit, Faculty of Medicine University of Kelaniya  Ragama Sri Lanka"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2015,9,16]]},"reference":[{"key":"e_1_2_10_2_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0050218"},{"key":"e_1_2_10_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.toxicon.2010.12.022"},{"key":"e_1_2_10_4_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0001255"},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0050221"},{"key":"e_1_2_10_6_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0030150"},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.292.6512.17"},{"key":"e_1_2_10_8_1","doi-asserted-by":"publisher","DOI":"10.1081\/CLT-120021113"},{"key":"e_1_2_10_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0041-0101(02)00393-8"},{"key":"e_1_2_10_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2005.12.1303"},{"key":"e_1_2_10_11_1","first-page":"730","article-title":"Low dose subcutaneous adrenaline to prevent acute adverse reactions to antivenom serum in snake bite: a randomized placebo\u2010controlled trial","volume":"318","author":"Premawardena AP","year":"1999","journal-title":"BMJ"},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0035-9203(01)90339-6"},{"key":"e_1_2_10_13_1","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.2004.tb05768.x"},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000435"},{"key":"e_1_2_10_15_1","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.1977.tb130959.x"},{"key":"e_1_2_10_16_1","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1080\/00034983.1987.11812096","article-title":"Antivenom reactions and complement depletion in snake bite","volume":"81","author":"Pugh RN","year":"1987","journal-title":"Ann Trop Med Parasitol"},{"key":"e_1_2_10_17_1","first-page":"366","article-title":"Antivenoms. A review of current status and future developments","volume":"7","author":"Theakston RDG","year":"1997","journal-title":"Biopharmaceuticals"},{"key":"e_1_2_10_18_1","first-page":"317","article-title":"Snake antivenoms","volume":"41","author":"Lalloo DG","year":"2003","journal-title":"J Toxicol Clin Toxicol"},{"key":"e_1_2_10_19_1","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.1998.58.183"},{"key":"e_1_2_10_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.toxicon.2011.11.017"},{"key":"e_1_2_10_21_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0002326"},{"key":"e_1_2_10_22_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0038739"},{"key":"e_1_2_10_23_1","doi-asserted-by":"crossref","first-page":"259","DOI":"10.4269\/ajtmh.1999.61.259","article-title":"A new monospecific ovine Fab fragment antivenom for treatment of envenoming by the Sri Lankan Russell's viper (Daboiarusseliirusselii): a preliminary dose\u2010finding and pharmacokinetic study","volume":"61","author":"Ariaratnam CA","year":"1999","journal-title":"Am J Trop Med Hyg"},{"key":"e_1_2_10_24_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.318.7196.1451"},{"key":"e_1_2_10_25_1","doi-asserted-by":"crossref","first-page":"734","DOI":"10.5694\/j.1326-5377.1992.tb141271.x","article-title":"Antivenom use in Australia: premedication, adverse reactions and the use of venom detection kits","volume":"157","author":"Sutherland SK","year":"1992","journal-title":"Med J Aust"},{"key":"e_1_2_10_26_1","first-page":"1041","article-title":"A plea for caution in the use of adrenaline","volume":"318","author":"Khanna R","year":"1999","journal-title":"BMJ"},{"key":"e_1_2_10_27_1","doi-asserted-by":"crossref","first-page":"48","DOI":"10.4038\/cmj.v47i2.3451","article-title":"Safety of subcutaneous adrenaline as prophylaxis against acute adverse reactions to anti\u2010venom serum in snakebite","volume":"47","author":"Dassanayake AS","year":"2002","journal-title":"Ceylon Med J"},{"key":"e_1_2_10_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0196-0644(96)70100-2"},{"key":"e_1_2_10_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.toxicon.2006.11.026"},{"key":"e_1_2_10_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2011.01.038"},{"key":"e_1_2_10_31_1","doi-asserted-by":"publisher","DOI":"10.1159\/000354543"},{"key":"e_1_2_10_32_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.2011.03779.x"},{"key":"e_1_2_10_33_1","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.2006.tb00563.x"},{"key":"e_1_2_10_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.toxicon.2013.09.010"},{"key":"e_1_2_10_35_1","doi-asserted-by":"publisher","DOI":"10.1038\/82691"},{"key":"e_1_2_10_36_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198411293112204"},{"key":"e_1_2_10_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.toxicon.2011.12.006"},{"key":"e_1_2_10_38_1","doi-asserted-by":"publisher","DOI":"10.1067\/mem.2001.113372"},{"key":"e_1_2_10_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annemergmed.2012.08.027"},{"key":"e_1_2_10_40_1","doi-asserted-by":"publisher","DOI":"10.1580\/1080-6032(2003)14[220:SSFAOA]2.0.CO;2"},{"key":"e_1_2_10_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(80)90469-6"},{"key":"e_1_2_10_42_1","doi-asserted-by":"crossref","first-page":"275","DOI":"10.5694\/j.1326-5377.1963.tb27211.x","article-title":"The treatment of snakebite","volume":"50","author":"Trinca GF","year":"1963","journal-title":"Med J Aust"},{"key":"e_1_2_10_43_1","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.1967.tb73914.x"},{"key":"e_1_2_10_44_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.161.16.2030"},{"key":"e_1_2_10_45_1","doi-asserted-by":"publisher","DOI":"10.1067\/mem.2002.123698"},{"key":"e_1_2_10_46_1","doi-asserted-by":"publisher","DOI":"10.1067\/mem.2002.129939"},{"key":"e_1_2_10_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annemergmed.2003.08.009"},{"key":"e_1_2_10_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annemergmed.2010.06.550"},{"key":"e_1_2_10_49_1","doi-asserted-by":"publisher","DOI":"10.18773\/austprescr.2006.078"},{"key":"e_1_2_10_50_1","first-page":"220","article-title":"Childhood serum sickness: a case report","volume":"34","author":"Chao YK","year":"2001","journal-title":"J Microbiol Immunol Infect"},{"key":"e_1_2_10_51_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra013477"}],"container-title":["British Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbcp.12739","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bcp.12739","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T14:38:43Z","timestamp":1694615923000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/10.1111\/bcp.12739"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,16]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["10.1111\/bcp.12739"],"URL":"https:\/\/doi.org\/10.1111\/bcp.12739","archive":["Portico"],"relation":{},"ISSN":["0306-5251","1365-2125"],"issn-type":[{"value":"0306-5251","type":"print"},{"value":"1365-2125","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,16]]}}}